Mutation‐Specific Phenotypes in hiPSC‐Derived Cardiomyocytes Carrying Either Myosin‐Binding Protein C Or <i>α</i>‐Tropomyosin Mutation for Hypertrophic CardiomyopathyKatriina Aalto‐Setälä, Chandra Prajapati, Risto-Pekka Pölönen et al.|Stem Cells International|2015Cited by 105
Sex differences in heart: from basics to clinicsChandra Prajapati, Katriina Aalto‐Setälä, Jussi T. Koivumäki et al.|European journal of medical research|2022Cited by 85
Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem CellsDisheet Shah, Katriina Aalto‐Setälä, Laura Virtanen et al.|Cells|2019Cited by 70
hiPSC-Derived Cardiomyocyte Model of LQT2 Syndrome Derived from Asymptomatic and Symptomatic Mutation Carriers Reproduces Clinical Differences in Aggregates but Not in Single CellsDisheet Shah, Katriina Aalto‐Setälä, Jari Hyttinen et al.|Cells|2020Cited by 30
Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathyChandra Prajapati, Katriina Aalto‐Setälä, Marisa Ojala|Disease Models & Mechanisms|2018Cited by 25